Merck KGaA (MKGAF) Stock Chart & Stock Price History $134.76 +0.05 (+0.04%) As of 07/3/2025 11:56 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort InterestBuy This Stock Merck KGaA Stock Price Performance The Merck KGaA (MKGAF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 20.40%, with a year-to-date return of -11.08%. In the past month, the stock has increased 1.51%, reflecting recent market activity. As of the latest close, Merck KGaA traded at $134.76 with a market cap of $17.42 billion and volume of 163 shares. Five years ago, the stock traded at $119.30, representing a 12.96% increase over that period. At the time, it had a market cap of $14.90 billion and a volume of 241 shares. Receive MKGAF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.68%1 Month Performance+1.51%3 Month Performance+7.42%Year-To-Date Performance-11.08%1 Year Performance-20.40%5 Year Performance+12.96% MKGAF Stock Chart for Saturday, July, 5, 2025 MKGAF Chart by TradingView Merck KGaA Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$134.76$134.76$134.99$129.47163 shs$17.42 billion07/03/2025$134.71$134.76+0.04%$134.99$129.47163 shs$17.42 billion07/02/2025$132.90$134.71+1.36%$134.71$130.3634 shs$17.41 billion07/01/2025$131.25$132.90+1.26%$134.95$129.05576 shs$17.18 billion06/30/2025$129.74$131.25+1.16%$133.05$129.001,173 shs$16.96 billion06/27/2025$128.50$129.74+0.96%$134.77$129.741,669 shs$16.77 billion06/26/2025$125.89$128.50+2.07%$133.64$128.50584 shs$16.61 billion06/25/2025$131.45$125.89-4.23%$132.78$125.89605 shs$16.27 billion06/24/2025$127.82$131.45+2.84%$132.85$127.20527 shs$16.99 billion06/23/2025$124.46$127.82+2.70%$129.40$124.251,270 shs$16.52 billion Get the Latest News and Ratings for MKGAF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$129.35$124.46-3.78%$124.95$124.4649 shs$16.08 billion06/19/2025$129.35$129.35$130.15$124.15583 shs$16.72 billion06/18/2025$130.20$129.35-0.65%$130.15$124.15583 shs$16.72 billion06/17/2025$133.50$130.20-2.47%$134.43$127.904,384 shs$16.83 billion06/16/2025$132.00$133.50+1.14%$135.80$130.1423,537 shs$17.25 billion06/13/2025$136.25$132.00-3.12%$135.44$129.70280 shs$17.06 billion06/12/2025$131.52$136.25+3.60%$137.45$133.52230 shs$17.61 billion06/11/2025$133.37$131.52-1.39%$138.99$129.9521,314 shs$17.00 billion06/10/2025$136.67$133.37-2.41%$136.05$130.951,069 shs$17.24 billion06/09/2025$129.70$136.67+5.37%$136.67$127.58522 shs$17.66 billion06/06/2025$132.75$129.70-2.30%$134.15$128.223,558 shs$16.76 billion06/05/2025$136.00$132.75-2.39%$135.21$132.75370 shs$17.16 billion06/04/2025$136.05$136.00-0.04%$136.00$129.91222 shs$17.58 billion Related Companies UCB Stock Price Chart Intra-Cellular Therapies Stock Price Chart MorphoSys Stock Price Chart Gemini Therapeutics Stock Price Chart Evotec Stock Price Chart Antibe Therapeutics Stock Price Chart Calliditas Therapeutics AB (publ) Stock Price Chart Zymeworks Stock Price Chart Chimerix Stock Price Chart Avid Bioservices Stock Price Chart Receive MKGAF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:MKGAF) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
